Table 1.
Participants | Donors |
Inclusion | |
Biological female at birth | Biological female at birth |
16–32 years of age | 18–32 years of age |
BMI 13–19 kg/m2 | BMI 18.5–25 kg/m2 |
Formal diagnosis of AN by an eating disorder specialist* | Total body fat ≤33% (as assessed by whole-body DXA) |
Medically stable† | Healthy diet (≥4 portions of fruit and/or vegetables/day) |
Able and willing to swallow the treatment capsules | Regular exercise (moderate-to-vigorous physical activity for ≥3.5 hours/week) |
Able and willing to comply with the clinical assessments | Regular bowel habit (passing stools at least once every 2 days) |
Exclusion | |
Known allergies to any foods or medications | Positive screening test for any transmissible pathogen or multidrug resistant organism listed in table 2 |
Use of antibiotics or probiotics in the month prior to treatment | Gastrointestinal disease (eg, inflammatory bowel disease, irritable bowel syndrome, coeliac disease or eosinophilic oesophagitis) |
Regular oral steroid treatment or daily application of potent topical steroids extensively to the body | Metabolic disorder (eg, diabetes, metabolic syndrome, hypertension, dyslipidaemia or dysglycaemia) |
Compromised immune system | Impaired fasting glucose (>5.9 mmol/L) or elevated HbA1c (>41 mmol/mol) |
Any other chronic illness affecting gut or metabolic health | Asthma or eczema requiring regular prophylaxis or treatment |
Thoughts of self-harm and/or suicidal ideation‡ | Autism spectrum disorder |
Current or planned pregnancy during the course of the study | Previous diagnosis of mental health issues including eating disorders |
Regular laxative use | Current or history of malignancy |
Use of oral antibiotics or probiotic supplements in the past 3 months | |
Regular binge drinking (>5 standard alcoholic units per session at least once a week) | |
Past or present use of recreational drugs, tobacco or vaping | |
Current or past pregnancy | |
Overseas travel in the past 2 weeks§ |
*Meeting the DSM-5 criteria, 307.1.
†In accordance with Starship Children’s Hospital’s clinical guidelines70 (ie, resting heart rate >50 bpm; no postural drop in blood pressure or rise in heart rate, no electrolyte abnormalities, and temperature >35°C and <37.8°C).
‡Based on response to question 9 of the Patient Health Questionnaire-9 (PHQ-9).60
§Donors who have travelled overseas will need to wait a minimum period of 2 weeks from their arrival back in New Zealand before donating.
AN, anorexia nervosa; BMI, body mass index; DSM-5, Diagnostic and Statistical Manual of Mental Disorders, fifth edition; DXA, dual-energy X-ray absorptiometry.